Our story
Odne AG (formerly Lumendo AG), has its roots in a groundbreaking collaboration between two renowned Swiss institutions: the Swiss Federal Institutes of Technology in Lausanne and Zürich (EPFL & ETH Zürich).
Founded in 2018, Odne’s journey began by licensing cutting-edge technology assets from these esteemed institutes and starting product development in close collaboration with dental KOLs and Universities.
In 2023, Odne received FDA-clearance for OdneFill and OdneCure. FDA-clearance for OdneClean followed in 2024. To support the US launch, Odne founded Odne Inc. and started its product launch with a Priority Access Program (PAP) at AAE annual meeting in Los Angeles.
Odne is transforming endo by pioneering the future of endodontics through advanced technology solutions.